We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$26.1B
AUM Growth
+$1.03B
(+4.1%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$94.2M |
| 2 |
Medtronic
MDT
|
+$83.5M |
| 3 |
Verizon
VZ
|
+$54.1M |
| 4 |
Adobe
ADBE
|
+$54.1M |
| 5 |
Amazon
AMZN
|
+$50.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$81.3M |
| 2 |
Sensata Technologies
ST
|
+$78M |
| 3 |
PG&E
PCG
|
+$52M |
| 4 |
Amgen
AMGN
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 11.2% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DF
1026
DELISTED
Dean Foods Company
DF
| $823K | ﹤0.01% |
78,300
+16,100
| +26% | +$152K |
|
|
SIVB
1027
DELISTED
SVB Financial Group
SIVB
| $814K | ﹤0.01% |
2,818
-36
| -1% | -$10.6K |
|
1028
Cincinnati Financial
CINF
$26.3B
| $812K | ﹤0.01% |
12,143
-1,496
| -11% | -$106K |
|
1029
Lumen
LUMN
$7.04B
| $812K | ﹤0.01% |
43,587
+27,320
| +168% | +$496K |
|
1030
MGM Resorts International
MGM
$9.87B
| $807K | ﹤0.01% |
27,779
-11,757
| -30% | -$380K |
|
|
CORR
1031
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $805K | ﹤0.01% |
21,400
+2,800
| +15% | +$104K |
|
1032
IQVIA
IQV
$44.4B
| $804K | ﹤0.01% |
8,050
-77,880
| -91% | -$7.78M |
|
1033
Pathward Financial
CASH
$1.65B
| $799K | ﹤0.01% |
+24,600
| New | +$893K |
|
1034
Banco Bradesco
BBD
$37B
| $794K | ﹤0.01% |
184,972
| – | – |
|
1035
Molson Coors Class B
TAP
$7.32B
| $790K | ﹤0.01% |
11,601
-6,275
| -35% | -$418K |
|
1036
Hecla Mining
HL
$12.5B
| $787K | ﹤0.01% |
226,100
+82,500
| +57% | +$314K |
|
1037
American Airlines Group
AAL
$8.45B
| $782K | ﹤0.01% |
20,599
+4,307
| +26% | +$190K |
|
|
SUNS
1038
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
| $776K | ﹤0.01% |
47,569
| – | – |
|
1039
UGI
UGI
$8.11B
| $772K | ﹤0.01% |
14,822
-25,978
| -64% | -$1.26M |
|
|
TTPH
1040
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $772K | ﹤0.01% |
10,817
| – | – |
|
1041
AerCap
AER
$21.7B
| $770K | ﹤0.01% |
14,220
-400
| -3% | -$21.5K |
|
1042
Information Services Group
III
$260M
| $770K | ﹤0.01% |
187,798
+165,900
| +758% | +$688K |
|
1043
NovoCure
NVCR
$1.88B
| $770K | ﹤0.01% |
24,600
| – | – |
|
1044
Dana Inc
DAN
$3.24B
| $759K | ﹤0.01% |
37,600
-14,900
| -28% | -$354K |
|
1045
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $751K | ﹤0.01% |
19,275
| – | – |
|
|
GLUU
1046
DELISTED
Glu Mobile Inc.
GLUU
| $749K | ﹤0.01% |
116,800
| – | – |
|
1047
Lifetime Brands
LCUT
$191M
| $745K | ﹤0.01% |
58,905
-15,900
| -21% | -$186K |
|
1048
DaVita
DVA
$12.2B
| $743K | ﹤0.01% |
10,712
-188
| -2% | -$12.6K |
|
|
CDK
1049
DELISTED
CDK Global, Inc.
CDK
| $741K | ﹤0.01% |
11,386
-3,592
| -24% | -$232K |
|
1050
ArcBest
ARCB
$3.01B
| $740K | ﹤0.01% |
+16,200
| New | +$667K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2018 Portfolio in Review
As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
- Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
- Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
- Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
- Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
- Axa opened 112 new positions and closed 130 in Q2 2018.
- Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.
Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.